scispace - formally typeset
Journal ArticleDOI

792 Do Concurrent Gastroprotective Agents Impact Gastrointestinal Bleeding Rates in Edoxaban Users? Results From the ENGAGE-AF TIMI 48 Trial

James Aisenberg, +11 more
- 01 Apr 2016 - 
- Vol. 150, Iss: 4
About: 
This article is published in Gastroenterology.The article was published on 2016-04-01. It has received 1 citations till now. The article focuses on the topics: Edoxaban & TIMI.

read more

Citations
More filters
Journal ArticleDOI

Risk of gastrointestinal bleeding during anticoagulant treatment.

Aitor Lanas-Gimeno, +1 more
- 17 May 2017 - 
TL;DR: Current evidence related to GIB associated with oral anticoagulants, focusing on randomized controlled trials, meta-analyses, and post-marketing observational studies is reviewed, finding there has been an important shift in the clinical presentation of GIB.
Related Papers (5)

Abstract 16612: Efficacy and Safety of Edoxaban for the Management of Elderly Patients With Atrial Fibrillation: Engage AF-TIMI 48

Eri Toda Kato, +10 more
- 25 Nov 2014 - 

Perioperative adverse outcomes in patients with atrial fibrillation taking edoxaban or warfarin: analysis of the engage af-timi 48 trial

James D. Douketis, +8 more
- 17 Mar 2015 - 

Edoxaban and amiodarone: interactions on multiple levels.

David Conen
- 01 Sep 2015 - 

Efficacy and safety of edoxaban in patients with atrial fibrillation and active malignancy: an analysis of engage af – timi 48 randomized clinical trial

Christina Fanola, +17 more
- 21 Mar 2017 - 

Efficacy and safety of edoxaban compared with warfarin according to the burden of diseases in patients with atrial fibrillation: insights from the ENGAGE AF-TIMI 48 trial

André M Nicolau, +12 more
- 01 May 2020 -